1. Sugimoto, Wataru, Itoh, Katsuhiko, Hirata, Hiroaki, Tanaka, Nobuyuki, Kawauchi, Keiko. 2020. MMP24 as a Target of YAP is a Potential Prognostic Factor in Cancer Patients. In Bioengineering (Basel, Switzerland), 7, . doi:10.3390/bioengineering7010018. https://pubmed.ncbi.nlm.nih.gov/32093160/
2. Ma, Longfei, Huang, Yangyuxin, Zhang, Fengjiang, Jiang, Bao-Chun, Yan, Min. 2021. MMP24 Contributes to Neuropathic Pain in an FTO-Dependent Manner in the Spinal Cord Neurons. In Frontiers in pharmacology, 12, 673831. doi:10.3389/fphar.2021.673831. https://pubmed.ncbi.nlm.nih.gov/33995105/
3. Kim, Bong Jun, Hong, Eun Pyo, Youn, Dong Hyuk, Jeon, Jin Pyeong. 2022. Genome-Wide Association Study of the Relationship Between Matrix Metalloproteinases and Intracranial Aneurysms. In Journal of clinical neurology (Seoul, Korea), 18, 163-170. doi:10.3988/jcn.2022.18.2.163. https://pubmed.ncbi.nlm.nih.gov/35196751/
4. Cloud, Ashley S, Vargheese, Aditya M, Gunewardena, Sumedha, Jensen, Roy A, Chennathukuzhi, Vargheese M. 2022. Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression. In BMC cancer, 22, 180. doi:10.1186/s12885-022-09280-2. https://pubmed.ncbi.nlm.nih.gov/35177031/